Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | B3GNT3 |
| Upstream (Parents) |
|---|
| (<<) ADORA2B → B3GNT3 |
| (<<) ATP10B → B3GNT3 |
| (<<) CDCP1 → B3GNT3 |
| (<<) DDR1 → B3GNT3 |
| (<<) ELF4 → B3GNT3 |
| (<<) FUT2 → B3GNT3 |
| (<<) LGALS3 → B3GNT3 |
| (<<) PRSS3 → B3GNT3 |
| (<<) SOX9 → B3GNT3 |
| (<<) UBE2C → B3GNT3 |
| Downstream (Children) |
|---|
| B3GNT3 → ACTN4 (>>) |
| B3GNT3 → ANKRD27 (>>) |
| B3GNT3 → ATP2C2 (>>) |
| B3GNT3 → CCNE1 (>>) |
| B3GNT3 → EDN1 (>>) |
| B3GNT3 → EFHD2 (>>) |
| B3GNT3 → ELF3 (>>) |
| B3GNT3 → FA2H (>>) |
| B3GNT3 → FERMT1 (>>) |
| B3GNT3 → HCN4 (>>) |
| B3GNT3 → ITGA2 (>>) |
| B3GNT3 → ITGB4 (>>) |
| B3GNT3 → MAPK13 (>>) |
| B3GNT3 → MST1R (>>) |
| B3GNT3 → OVOL1 (>>) |
| B3GNT3 → PLCB4 (>>) |
| B3GNT3 → PRKAB1 (>>) |
| B3GNT3 → S100P (>>) |
| B3GNT3 → SH3GLB2 (>>) |
| B3GNT3 → SPRY2 (>>) |
